Insuman Comb 25 Solostar

Insulin Human, the active ingredient in Insuman Comb 25 Solostar, is an insulin presented as a subcutaneous injectable for diabetes management. It is used to regulate blood glucose levels in patients with diabetes mellitus. GNH USA supplies Insuman Comb 25 Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 25 Solostar provides insulin therapy for the diabetes mellitus disease family.

- Diabetes mellitus: helps achieve target blood glucose control. - Type 1 diabetes: supplies basal and prandial insulin to replace deficient endogenous insulin. - Type 2 diabetes: used when oral antidiabetic agents are insufficient to maintain glycaemic goals.

Insuman Comb 25 Solostar may cause a range of adverse reactions.

Common Side Effects: - Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, and confusion. - Injection‑site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase in body weight with chronic use. - Lipodystrophy: localized changes in fat tissue at injection sites. - Edema: mild peripheral swelling, especially in the lower limbs. - Headache: occasional mild to moderate headache.

Serious or Rare Side Effects: - Severe hypoglycaemia: profound low blood glucose requiring assistance. - Allergic reactions: urticaria, angio‑edema, or anaphylaxis. - Insulin antibodies: formation of antibodies that may alter insulin action. - Serum sickness‑like reactions: fever, rash, arthralgia in rare cases.

When using Insuman Comb 25 Solostar, several safety considerations apply.

- Dose individualisation: adjust dose based on frequent blood glucose monitoring. - Hypoglycaemia risk: avoid administration if patient is already experiencing low glucose. - Illness management: increase monitoring and possibly adjust dose during acute illness. - Renal/hepatic impairment: use with caution and consider dose reduction. - Concomitant medications: be aware of drugs that may mask hypoglycaemia symptoms. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 25 Solostar can interact with other medicines, affecting glucose control.

Major Interactions (Avoid): - Sulfonylureas or meglitinides: combined use may cause severe hypoglycaemia. - High‑dose alcohol: can potentiate insulin’s glucose‑lowering effect. - Beta‑blockers: may mask typical hypoglycaemia warning signs.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance insulin sensitivity, requiring dose review. - Corticosteroids: can increase blood glucose, necessitating higher insulin doses. - Thiazide diuretics: may raise glucose levels, requiring closer monitoring. - Thyroid hormones: can alter insulin requirements. - Beta‑blockers (monitor): may blunt autonomic responses to low glucose.